Results 191 to 200 of about 4,452,010 (286)

Cost of adapting the International Guide for Monitoring Child Development, Guatemala and India. [PDF]

Bull World Health Organ
Tschida S, Mundra A, Mustafa R, Bandal A, Guarchaj M, Choy K, Das P, Hernandez S, Kalantri A, Raut AV, Sane A, Srinivasan R, Krishnamurthy V, Ertem I, Gupta SS, Rohloff P, Lu C.   +16 more
europepmc   +1 more source

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

Response to the Letter to the Editor Entitled "Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits". [PDF]

Kidney Int Rep
Costes-Albrespic M, Alencar de Pinho N, Massy ZA, Liabeuf S.   +3 more
europepmc   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Inhibition of RhoA-mediated secretory autophagy in megakaryocytes mitigates myelofibrosis in mice. [PDF]

Nat Commun
Becker IC, Branfield S, Barrachina MN, Camacho V, Lykins J, Stone AP, Walsey E, Bennani M, Chua BA, Signer RAJ, Machlus KR, Whiteheart SW, Roweth HG, Italiano JE.   +13 more
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

Insulin resistance induced by pesticides is overcome by pancreatic islet adaptation in a mouse model of Parkinson's disease. [PDF]

Mol Metab
Arrar A, Mesto N, Descaillot R, Humo M, De Cesar A, Gaillard D, Lakhdar L, Vulin J, Aufauvre C, Baumier R, Bellières C, Imbert J, Perrier P, Jamin EL, Vuillaume R, Arsac JN, Fougerat A, Ravier MA, Baron T, Gamet-Payrastre L, Costes S.   +20 more
europepmc   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

Arthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger   +6 more
wiley   +1 more source

[Cost-Effectiveness Analysis of an ICTUS Unit: A Case Study of the University Hospital Complex of Santiago de Compostela]. [PDF]

Rev Neurol
Reyes-Santias F, Castro ADCP, Santamaria-Cadavid M, Castro E, Rodriguez-Yañez M, Prieto-Gonzalez JM, Aibar-Guzman B.   +6 more
europepmc   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

Arthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin, Candace H. Feldman, Claire E. H. Barber, Gabriel Fabreau, Jake Jennings, Scott Patten, Cheryl Barnabe, Inflammatory Arthritis‐Specific ACSC Consensus Process Working Group   +7 more
wiley   +1 more source